Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease

被引:68
作者
Zoccali, C [1 ]
Mallamaci, F [1 ]
Tripepi, G [1 ]
机构
[1] Ist Biomed, Lab Epidemiol Clin & Fisiopatol Malattie Renali &, Reggio Di Calabria, Italy
关键词
adipose tissue; leptin; adiponectin; cytokines; IL-6; TNF-alpha; cardiovascular risk; nutrition; ESRD; uremia; dialysis;
D O I
10.1046/j.1523-1755.63.s84.50.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Adipose tissue is a necessary survival characteristic of species that do not have constant access to food. TNF-alpha is a very fundamental "internal regulator" (intra-system) of adipose tissue metabolism, and IL-6 and IL-1beta are relevant control factors, as well. Leptin and IL-6, but not TNF-alpha, appear to be the major signals linking adipose tissue to the systemic immunologic response. In ESRD, it has been coherently observed that acute-phase reactants like CRP and serum amyloid A are independently associated to atherosclerosis, death, and cardiovascular complications. Leptin is inversely related with plasma creatinine, suggesting that reduced renal clearance is a primary factor responsible for hyperleptinemia in ESRD. On the other hand, this adipose tissue hormone behaves as an inverse acute-phase reactant (i.e., it decreases during spontaneous episodes of the acute-phase response). Dialysis patients with hyperleptinemia have more severe degrees of insulin resistance but further studies are required to see whether leptin plays a role in insulin resistance in these patients. The most abundant protein synthesized in the adipose tissue, adiponectin, is inversely related to metabolic risk factors like glucose, triglycerides, insulin, and HDL cholesterol in uremic patients, suggesting that this cytokine is a protective factor for the cardiovascular system. Accordingly, plasma adiponectin is an independent, inverse predictor of incident cardiovascular events in dialysis patients.
引用
收藏
页码:S65 / S68
页数:4
相关论文
共 22 条
  • [1] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [2] Modulation of insulin secretion by leptin
    Ceddia, RB
    William, WN
    Carpinelli, AR
    Curi, R
    [J]. GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1999, 32 (02): : 233 - 237
  • [3] Serum immunoreactive leptin concentrations in normal-weight and obese humans
    Considine, RV
    Sinha, MK
    Heiman, ML
    Kriauciunas, A
    Stephens, TW
    Nyce, MR
    Ohannesian, JP
    Marco, CC
    McKee, LJ
    Bauer, TL
    Caro, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 292 - 295
  • [4] Don BR, 2001, KIDNEY INT, V59, P1114
  • [5] Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans
    Fawcett, RL
    Waechter, AS
    Williams, LB
    Zhang, PL
    Louie, R
    Jones, R
    Inman, M
    Huse, J
    Considine, RV
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) : 530 - 535
  • [6] ROLE OF CYTOKINES IN INDUCING HYPERLIPIDEMIA
    FEINGOLD, KR
    GRUNFELD, C
    [J]. DIABETES, 1992, 41 : 97 - 101
  • [7] FRIED SK, 1989, J LIPID RES, V30, P1917
  • [8] Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
    Hotta, K
    Funahashi, T
    Arita, Y
    Takahashi, M
    Matsuda, M
    Okamoto, Y
    Iwahashi, H
    Kuriyama, H
    Ouchi, N
    Maeda, K
    Nishida, M
    Kihara, S
    Sakai, N
    Nakajima, T
    Hasegawa, K
    Muraguchi, M
    Ohmoto, Y
    Nakamura, T
    Yamashita, S
    Hanafusa, T
    Matsuzawa, Y
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1595 - 1599
  • [9] Immunologic function and survival in hemodialysis patients
    Kimmel, PL
    Phillips, TM
    Simmens, SJ
    Peterson, RA
    Weihs, KL
    Alleyne, S
    Cruz, I
    Yanovski, JA
    Veis, JH
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (01) : 236 - 244
  • [10] Mallamaci F, 1997, J AM SOC NEPHROL, V8, pA1128